Nykredit Realkredit A/S
26.1.2021 09:05:34 CET | Globenewswire | Press release
To Nasdaq Copenhagen
26 January 2021
Nykredit Realkredit A/S – New final terms for Euro Medium Term Note
Programme
Nykredit Realkredit A/S publishes final terms for an issue of SEK 500,000,000 Floating Rate Senior Non-Preferred Notes due 2026, which are issued pursuant to Nykredit Realkredit A/S's and Nykredit Bank A/S’s €10,000,000,000 Euro Medium Term Note Programme dated 13 May 2020.
The final terms dated 26 January 2021 and the EMTN Programme dated 13 May 2020 are available for download on Nykredit's website at nykredit.com/ir.
Enquiries may be addressed to Nykredit Realkredit A/S, Nicolaj Verdelin, Head of Funding Trading, Funding & Capital, tel +45 44 55 11 25, or Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Leading Edge Materials Corp.19.6.2026 23:00:00 CEST | Press release
LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO APRIL 30, 2026
Scandinavian Tobacco Group A/S19.6.2026 15:30:00 CEST | Press release
Scandinavian Tobacco Group - Notification and Public Disclosure of Transactions by Persons
Agat Ejendomme A/S19.6.2026 15:10:00 CEST | Pressemeddelelse
Delårsrapport, 1. kvartal 2026/27
Dassault Aviation19.6.2026 14:13:36 CEST | Press release
Dassault Aviation: Dassault’s Falcon 10X Makes Maiden Flight
Sanofi Winthrop Industrie19.6.2026 12:31:00 CEST | Press release
Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
